$RENB - Cutting Edge AI Company GEDiCube and Cyclo
Post# of 94115
![](/assets/46931549/no_avatar_available_thumb.jpg)
From the article:
A Binding LOI has been executed: GEDiCube will acquire 75% of Cyclomics at Closing.
Expected breakthroughs by combining technologies in (early) cancer detection and recurrence of cancer with a single vial of blood.
Cyclomics’ 4th generation liquid biopsy genomics platform is a truly “Omni-Omic” blood test ready for AI application
GEDiCube’s award-winning AI is developing high-performance biomarker panels for 13 different cancers.
GEDiCube’s partnership with NVIDIA’s Inception program will help expand to multi-modal capabilities by adding imaging.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)